ArticleBMC cancer2018

PD-1 blockade in combination with zoledronic acid to enhance the antitumor efficacy in the breast cancer mouse model.

Yuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.